289 related articles for article (PubMed ID: 18847324)
1. Activation of renin-angiotensin system induces osteoporosis independently of hypertension.
Asaba Y; Ito M; Fumoto T; Watanabe K; Fukuhara R; Takeshita S; Nimura Y; Ishida J; Fukamizu A; Ikeda K
J Bone Miner Res; 2009 Feb; 24(2):241-50. PubMed ID: 18847324
[TBL] [Abstract][Full Text] [Related]
2. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
3. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor.
Flesch M; Höper A; Dell'Italia L; Evans K; Bond R; Peshock R; Diwan A; Brinsa TA; Wei CC; Sivasubramanian N; Spinale FG; Mann DL
Circulation; 2003 Aug; 108(5):598-604. PubMed ID: 12874189
[TBL] [Abstract][Full Text] [Related]
4. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
6. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin system and the developing retinal vasculature.
Sarlos S; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
[TBL] [Abstract][Full Text] [Related]
8. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
Azizi M
Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
[TBL] [Abstract][Full Text] [Related]
9. Dependence of angiotensin production in transgenic mice carrying either the human renin or human angiotensinogen genes on species-specific kinetics of the renin-angiotensin system.
Fukamizu A; Takimoto E; Sugimura K; Hatae T; Seo MS; Takahashi S; Sugiyama F; Kajiwara N; Yagami K; Murakami K
Arzneimittelforschung; 1993 Feb; 43(2A):222-5. PubMed ID: 8498968
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
11. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
14. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
15. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
16. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
17. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
18. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
20. Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
Dechend R; Shagdarsuren E; Gratze P; Fiebeler A; Pilz B; Meiners S; Derer W; Feldman DL; Webb R; Muller DN
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):81-4. PubMed ID: 17703434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
